🚨 JUST IN: $VVOS
Vivos Therapeutics to issue $12M Series C preferred for 11% SOD Sciences stake and 50% test co-ownership

🚨 JUST IN: $VVOS
Vivos Therapeutics to issue $12M Series C preferred for 11% SOD Sciences stake and 50% test co-ownership
#VVOS Vivos Therapeutics Agrees to Acquire Minority Stake in SOD Sciences and 50% Interest in Proprietary Pseudohypoxia Test
#VVOS Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives
#VVOS Vivos Therapeutics Announces Material Debt Reduction